The Ella B. Cleveland Trust is a philanthropic foundation managed by Wells Fargo Bank, N.A., with a focused mission to support medical research. Specifically, the trust funds research efforts aimed at the cause, treatment, cure, and alleviation of three targeted conditions: leukemia, muscular dystrophy, and cerebral palsy. The trust exclusively supports nonprofit organizations that qualify under Section 501(c)(3) of the Internal Revenue Code.

Although there are no formal geographic restrictions, the trust typically supports organizations based in Georgia. Despite this historical practice, 501(c)(3) organizations located in any U.S. state may apply and are considered for funding if their research aligns with the trust’s mission. Only research in the three named medical conditions is eligible for funding. Grants are not available for general health initiatives or unrelated diseases.

Applications are accepted year-round, but to be considered for the annual grant cycle, submissions must be completed by June 30. All qualified applications submitted by this deadline will be reviewed at the annual grant meeting held in July. Applicants are typically notified of the foundation’s decisions by August. Once an application is submitted, an automated email confirming receipt is sent to the applicant.

Grantees may be asked to submit periodic progress reports and a final report detailing outcomes related to the funded research. The online application portal is available through the Wells Fargo Trust Philanthropic Services website, where organizations can start and submit their applications electronically.

For any questions related to the application process, applicants should contact Wells Fargo Trust Philanthropic Services. While direct contact information is not specified in the provided materials, support is available through the online application portal.